WST
West Pharmaceutical Services Inc Earnings
$246.34
Earnings Summary
Revenue | $766.5Mn |
Net Profits | $131.8Mn |
Net Profit Margins | 17.2% |
PE Ratio | 37.03 |
West Pharmaceutical Services Inc’s revenue jumped 9.19% since last year same period to $766.5Mn in the Q2 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 9.81% jump in its revenue since last 3-months.
West Pharmaceutical Services Inc’s net profit jumped 18.42% since last year same period to $131.8Mn in the Q2 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 46.77% jump in its net profits since last 3-months.
West Pharmaceutical Services Inc’s net profit margin jumped 8.45% since last year same period to 17.2% in the Q2 2025. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 33.65% jump in its net profit margins since last 3-months.
West Pharmaceutical Services Inc’s price-to-earnings ratio after this Q2 2025 earnings stands at 37.03.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.68 |
EPS Estimate Current Year | 1.68 |
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.68 - a 11.26% jump from last quarter’s estimates.
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.68.
Key Ratios
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.21 |
West Pharmaceutical Services Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the West Pharmaceutical Services Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
West Pharmaceutical Services Inc declared 0.21 dividend per share during the earnings announcement for Q3 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-10-23 | 1.68 | 0 | -100% |
2025-07-24 | 1.51 | 1.84 | 21.85% |
2025-04-24 | 1.26 | 1.45 | 15.27% |
